logo

For the Inventor, By the Inventor

Kashiwa, Japan

Nanocarrier Co., Ltd.

Calculating rank
USPTO Granted Patents = 23

% Expired Patents = 60.9



Forward Citations = 105

Loading Chart...
Loading Chart...

51 inventors (with patents filed for the assignee):

goldMedal Yasuki Kato (12 out of 14 patents)

silverMedal Kazunori Kataoka (11 out of 77 patents)

bronzeMedal Nobuhiro Nishiyama (6 out of 35 patents)

4.  Mitsunori Harada (6 out of 7 patents)

5.  Yukio Nagasaki (5 out of 41 patents)

6.  Atsushi Ishii (4 out of 72 patents)

7.  Kanjiro Miyata (4 out of 21 patents)

8.  Naoya Shibata (4 out of 13 patents)

9.  Shigeto Fukushima (3 out of 10 patents)

10.  Takashi Shimizu (2 out of 150 patents)

11.  Hiroyasu Takemoto (2 out of 13 patents)

12.  Sumiyo Watanabe (2 out of 3 patents)

13.  Kensuke Osada (2 out of 5 patents)

14.  Hiroyuki Chaya (2 out of 4 patents)

15.  Katsutoshi Kobayashi (2 out of 2 patents)


23 patents:

1. 11020418 - Unit structure-type pharmaceutical composition for nucleic acid delivery (2021-06-01),
2. 9920133 - Anti-tissue factor monoclonal antibody (2018-03-20),
3. 9808480 - Unit structure-type pharmaceutical composition for nucleic acid delivery (2017-11-07),
4. 9795563 - Particulate pharmaceutical composition (2017-10-24),
5. 9561284 - Pharmaceutical composition containing a block copolymer bound to a boronic acid compound (2017-02-07),
6. 9415059 - Particulate composition and pharmaceutical composition containing the same (2016-08-16),
7. 9278075 - Particle composition and pharmaceutical composition using particle composition (2016-03-08),
8. 9198860 - Particulate pharmaceutical composition (2015-12-01),
9. 9114177 - Block copolymer having phenylboronic acid group introduced therein, and use thereof (2015-08-25),
10. RE45471 - Pharmaceutical composition or combination drug (2015-04-13),
11. 8895076 - Liquid composition of cisplatin coordination compound (2014-11-25),
12. 8853167 - Short-chain cationic polyamino acid and use thereof (2014-10-07),
13. 8574601 - Sustained-release polymer micelle disruptable by HDL (2013-11-05),
14. 8519051 - Block copolymer for drug conjugates and pharmaceutical composition (2013-08-27),
15. 8436044 - Pharmaceutical composition or combination drug (2013-05-07),
Company Overview
Nanocarrier Co., Ltd. is a biotechnology company based in Kashiwa, Japan, specializing in the development of innovative drug delivery systems. The company focuses on utilizing nanotechnology to enhance the efficacy and safety of therapeutic agents, particularly in the field of oncology. Through its advanced research initiatives, Nanocarrier aims to improve patient outcomes by creating targeted delivery mechanisms that minimize side effects and maximize therapeutic impact. The organization is committed to advancing healthcare solutions through cutting-edge scientific research and development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

23 Patents

#2 in Kashiwa

#2,708 in Japan

#27,736 in the World

Kashiwa, JP
Kashiwa, Japan

Nanocarrier Co., Ltd.

Forward Citations = 105

51 inventors:

goldMedal Yasuki Kato (12 out of 14 patents)

silverMedal Kazunori Kataoka (11 out of 77 patents)

bronzeMedal Nobuhiro Nishiyama (6 out of 35 patents)

4.  Mitsunori Harada (6 out of 7 patents)

5.  Yukio Nagasaki (5 out of 41 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nanocarrier Co., Ltd.. Retrieved from https://idiyas.com/company/nanocarrier-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…